The caption of image goes here

Cape to Cape Gutsy Challenge

The GI Cancer Institute invites you to support our courageous trekkers undertaking the 2019 Cape to Cape Gutsy Challenge this September.


Each of these trekkers will be walking over 135kms to show how 'Gutsy' they really are and raise vital funds for research to improve outcomes for those diagnosed with gastro-intestinal (GI) cancer.


GI cancer is a term for the group of cancers that affect the digestive system. This includes oesophageal, stomach, pancreas, gallbladder, biliary tract, liver, small intestine, and colorectal cancers.


With 3 people diagnosed every hour and 38 Australians dying every day, GI cancers are the most common in Australia.


This Gutsy Challenge will support an annual Innovation Fund Grant awarded to critical new early stage research in to new treatments for the 28,900 Australians diagnosed with a GI cancer every year.


“Our Innovation Fund grant provides researchers with the opportunity to conduct ground-breaking research in areas that have not been studied before. It is an important early step in the process to develop new clinical trials,” commented Professor Tim Price, Chair of the GI Cancer Institute board. “The Fund awards initiatives that will build on our research programs and enable our members to accumulate the data and evidence required to then approach funding bodies to progress to larger scale clinical trials.”


The Cape to Cape Gutsy Challenge team this year is led by Dr Lorraine Chantrill, one of our Board Members and the Head of Medical Oncology at Wollongong Hospital. Her motivation for taking on this challenge is personal. As she explains: 


“As part of my medical practice, every day, I see families affected by pancreatic cancer” she goes on to say “I have been participating in clinical trials to find a better way to treat my patients and I am walking this trek to honour a promise I have made to those I have treated to do whatever I can to improve the life expectancy.”


Supporting the team will directly enable clinical trial research critically needed to give those Australians diagnosed with GI Cancer and their loved ones hope.

Top Fundraisers
Raised so Far

Why the GI Cancer Institute


The GI Cancer Institute saves lives by funding gastro-intestinal (GI) cancer clinical trials research in Australia.


GI Cancers are the most common form of cancer, directly affecting more than 28,900 Australians each year and claiming a devastating 38 lives a day.


The research that we fund enables Australians with GI cancer to receive the best medical treatment. By conducting research in Australia, our cancer patients receive new treatments three to five years earlier than if the research was to take place overseas.


Our clinical trials allow us to find better ways to treat GI cancers.

About Huma Charity Challenge

When joining a Huma Charity Challenge you embark on a remarkable journey to discover your inner philanthropist - fundraising for a cause that is important to you.


At the same time, you also partake in an adventure ... perhaps even testing personal boundaries as you take on the physical challenge too!